personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
In the month’s issue, we examine what lessons from pandemic influenza can be applied to COVID-19 – featuring Russell Basser from Seqirus. We then move far beyond the pandemic to deep space – asking how biologic medicines can be made on-demand for astronauts on long-term space missions. In Profession, Ross T. Burn, CEO at CatSci walks us through the career experiences that have helped shape him, and in NextGen, we find out what can be done to reduce the global incidence of diabetes and its associated conditions. Brexit preparedness, precious metal catalysis, and post-pandemic pharma are all discussed in In My View. And finally, we sit down with Will Downie, CEO of Vectura Group, UK.